
Episode 70b Do Over: Predicting Preeclampsia, the PRAECIS trial
Published on Nov 16
34分钟
0:000:00
<p>The Filtrate:</p><p><strong>Joel Topf</strong></p><p><strong>Swapnil Hiremath</strong></p><p>With Special Guest:</p><p><strong>Michelle Hladunewich</strong>, Nephrologist at the University of Toronto</p><p><strong>Mir Melamed</strong>, Maternal-Fetal Medicine at the University of Toronto</p><p>Editor </p><p><strong>Simon Topf</strong></p><p>Show Notes</p><p>Priscilla Smith’s letter:</p><p>Dear Joel and the Freely Filtered team,</p><p>I am a long-time fan of your podcast and was looking forward to hearing your recently aired discussion of the Praecis study of sflt1:PlGF use in preeclampsia. Preeclampsia and renal disease in pregnancy are areas that many nephrologists report a lack of knowledge or confidence in discussing and managing. I am a nephrologist who has been co-leading a renal pregnancy clinic in London while writing a PhD on progression of renal disease in pregnancy. I have had the immense privilege of working with experts and key opinion leaders in preeclampsia research bo...